Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 396 publications
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.
Journal: bioRxiv : the preprint server for biology
Published: June 29, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026
The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor population.
Journal: Neuro-oncology practice
Published: March 09, 2026
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System Tumor.
Journal: medRxiv : the preprint server for health sciences
Published: January 16, 2026
Evaluating Dysphonia Referrals to Otolaryngology Providers: Is There a Need For Improved Referral Guideline Implementation?
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: December 30, 2025
Clinical outcome assessment trends in neuro-oncology trials.
Journal: Neuro-oncology practice
Published: December 29, 2025
Discovery of genetic susceptibility variants in pediatric and adult ependymoma.
Journal: Neuro-oncology advances
Published: December 12, 2025
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.
Journal: Neuro-oncology advances
Published: December 10, 2025
Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas.
Journal: Neuro-oncology advances
Published: October 27, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axis.
Journal: Neuro-oncology advances
Published: October 01, 2025
Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participants.
Journal: Neuro-oncology practice
Published: September 16, 2025
Last Updated: 09/26/2026